dev – Argenica Therapeutics

07 Nov 2019Poly-arginine-18 peptides do not exacerbate bleeding, or improve functional outcomes following collagenase-induced intracerebral hemorrhage in the ratReference: Liddle L, Reinders R, South SM, David Blacker DJ, Knuckey NW, Colbourne F, Melon BP (2019). Poly-arginine-18 peptides do not exacerbate bleeding, or improve functional outcomes following collagenase-induced intracerebral hemorrhage in the rat. PloS One, 4:e0224870. DOI: org/10.1371/journal.pone.0224870.
07 Nov 2019Poly-arginine peptides R18 and R18D improve functional outcomes after endothelin-1-induced stroke in the Sprague Dawley ratReference: Meloni BP, South SM., Gill, DA, Marriott AL, Déziel RA, Jacques A, Blacker DJ, Knuckey NW (2019). Poly-arginine peptides R18 and R18D improve functional outcomes after endothelin-1-induced stroke in the Sprague Dawley rat. Journal of Neuropathology and Experimental Neurology, 78:426-435. DOI: 10.1093/jnen/nlz014.

17 Apr 2020Poly-arginine peptide-18 (R18) reduces brain injury and improves functional outcomes in a non-human primate stroke modelReference: Meloni BP, Chen, Y, Harrison KA, Nashed JY, Blacker DJ, South SM, Anderton RS, Mastaglia FL, Winterborn A, Knuckey NW, Cook DJ (2020). Poly-arginine peptide-18 (R18) reduces brain injury and improves functional outcomes in a non-human primate stroke model. Neurotherapeutics, 17:627-634. DOI: 10.1007/s13311-019-00809-1.